Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. - sprookjes - yvandenbroek - TriplyDB

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37638675

about

HMG CoA reductase inhibitors (statins) for dialysis patients Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses Vascular calcification, bone and mineral metabolism after kidney transplantation High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis The Ariadne principles: how to handle multimorbidity in primary care consultations.Diabetic kidney disease: a report from an ADA Consensus Conference Lipid abnormalities in kidney disease and management strategies Clinical therapeutic strategies for early stage of diabetic kidney disease.Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?Strategies to support recruitment of patients with life-limiting illness for research: the Palliative Care Research Cooperative Group.Statin use in patients with cirrhosis: a retrospective cohort study.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level.Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice.Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study Association between higher rates of cardioprotective drug use and survival in patients on dialysis The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease Comprehensive Care for People With Diabetic Kidney Disease Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study Effects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease.Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study.Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.Modulation of stroke risk in chronic kidney disease.Effects of Atorvastatin Dose and Concomitant Use of Angiotensin-Converting Enzyme Inhibitors on Renal Function Changes over Time in Patients with Stable Coronary Artery Disease: A Prospective Observational Study.Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).Association between LDL-C and risk of myocardial infarction in CKD Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease

P2860

Q24198108-DA131DC2-E059-428E-9F9D-10237D6FB732 Q24289205-5CE2F5D2-ADE5-463D-9F8A-91B32174CB58 Q26771400-182C5BCA-E763-4C99-BCB2-E7B32E360E93 Q26853061-67875A21-9FDE-427A-B051-CF95BC249558 Q26864733-3CC0A820-EE94-4E50-AC1B-0D46070CC5D3 Q27012546-118CDB7B-BB3A-4253-B532-9A75C1A75F4F Q27024982-261CAB83-42C1-4BD4-9545-A0016785598E Q30363683-30004FD7-D3BA-4FA8-9E26-0BB187209C09 Q33716655-42CDAC4C-32C8-49A7-A263-392FEC9946FC Q34005232-C50B95F8-CDC5-4A76-9AFC-B896486CDDEF Q34045750-EF3115CC-F100-47D4-946D-F928E8895311 Q34411415-EE797634-144E-47C0-B755-C2302355221C Q34429278-E7223BEB-7053-4440-BDDD-08D71A1CD925 Q34508691-6911A204-0397-43D4-878F-82B9A3C73C08 Q34536800-4C82D48D-BD02-4AB9-AB00-7BA5AC1ED590 Q34561028-585E7728-20E4-43E2-9545-C920F8FBE47F Q34661975-B45D863B-26A6-46A8-A90B-59500EE64310 Q34736194-9CC9D3E8-B4CC-49D4-B4C1-923053ACD73B Q34820403-158E942A-DCDD-417D-BDF0-40BC11E6CA12 Q34985796-AA514DD2-7F0E-41C9-BB74-21C0523D1A36 Q35007909-B9B675AB-C048-4297-B42E-314DE5C7EF7A Q35045451-BAA2BCF9-E8D4-44D0-B8C2-C72E968129E9 Q35047636-70599A05-E13A-4573-871B-14B48CA7DAD4 Q35576102-0F5BE1E4-98B7-4BC9-BD91-20BD58B8927F Q35675305-68420D3C-80A6-4E61-9D6E-AEF1FED85212 Q35792795-FA160C74-E2F2-4D5B-91E8-88BE92DDDD15 Q35807113-A3FE24A2-693A-4A74-B38D-198A2EC5EDCC Q35812557-693C9E84-74C7-49BF-9DA5-9AF6E8E2134E Q35914820-54CF86EC-E438-49E5-99FF-FCF7735DB817 Q35953885-01548877-9FF7-4D36-881D-87F4EB0F2A4C Q36110666-7840B849-B0EA-4CE5-A603-2684659FC518 Q36199235-B0D7D481-7421-4EDF-90FA-B87572DC38C2 Q36218278-EDFAB34E-1081-496F-A0C7-6EEC77858739 Q36327959-20ABA1F9-FFCF-49A4-99E6-1484514682B9 Q36365884-7E94A6E3-6313-47B5-8A01-5E4648BD9CE1 Q36482963-1DEF4FFE-B4AA-4D90-917D-EF1CA60CA490 Q36666907-8B713317-B86C-4499-B286-61B9591C1CED Q36711180-97FA71B3-7675-4EBD-A5A6-AE7AA69D4BD9 Q36880435-6340F82B-9872-4F4E-B64E-0496D55A5C4B Q36943996-025C4064-843C-4AAB-959A-E819E542B52C

P2860

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37638675

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Benefits and harms of statin t ...... atic review and meta-analysis.

@en

Benefits and harms of statin t ...... atic review and meta-analysis.

@nl

type

label

Benefits and harms of statin t ...... atic review and meta-analysis.

@en

Benefits and harms of statin t ...... atic review and meta-analysis.

@nl

prefLabel

Benefits and harms of statin t ...... atic review and meta-analysis.

@en

Benefits and harms of statin t ...... atic review and meta-analysis.

@nl

P1433

Q37638675-C15B1736-4FFA-4309-9A68-9DF57391B13F

P1476

Q37638675-ECBBFAAC-6196-4746-B8F6-A57D4B80B76B

P2093

Q37638675-4F899637-138F-4751-80A6-C120D6DCE548

Q37638675-57A7A73B-63A5-406D-8F11-FC85057EC39C

Q37638675-C49E122B-5E4D-469E-9094-45A92F956364

Q37638675-DD782632-291C-484B-A1F4-21A0CEF9049B

Q37638675-E363D088-96DD-45D5-A4DA-59D24EAA8BBF

P2860

Q37638675-013F0233-02BD-4785-A5A5-20F295CE5C32

Q37638675-03837B29-5C39-493A-94FF-B8816FF8E6AC

Q37638675-08DDF68C-6750-4791-BAD8-16E5821677D3

Q37638675-0955E276-C695-425C-AE52-49CD07AD23DD

Q37638675-145A54D9-B8A2-4A05-8AD1-F5D4CE72F2F2

Q37638675-16266BBB-17B7-4312-96C5-78FB4C3F3A95

Q37638675-187BEF50-F915-4AF5-AE19-6FD46C3A6C7F

Q37638675-1D29423B-FF3D-4B16-9915-D8FAA8A6A9AC

Q37638675-2323305C-D584-4962-B576-708887B11E6D

Q37638675-23DC40D3-AD3E-44EC-B7B4-FC3D9595D007

P304

Q37638675-94FC8C52-64D2-47AF-A39D-A25F5716A135

P31

Q37638675-08A4C188-AD43-4BFB-88AF-37A70619D850

Q37638675-602dd0dd-cae4-4ae2-854c-59b8b8c8f47b

P356

Q37638675-4836E5EF-D766-487A-9593-076093833E51

P407

Q37638675-4DAC79B3-3CF1-47E6-9340-C49BA2F164E8

P433

Q37638675-3961D901-3580-4B3A-9828-C0AED380E19C

P478

Q37638675-DBBFB996-B856-4DC0-A9BB-EF56801933E0

P50

Q37638675-9E838CD1-15AE-43C8-8CF3-709D9B133D36

P577

Q37638675-BEECED66-9549-49BC-875D-B522FD4CB3AB

P698

Q37638675-A5357B33-E9E3-4E2A-A3F0-D5B4B13E9F11

P921

Q37638675-00CBC5DE-6703-4E73-86AB-278FE000E45B

Q37638675-8713D5E2-52C2-4AB7-8923-AE4BAA5E6329

P932

Q37638675-FD54DFE0-C38D-43ED-9FBE-CA56FA5ED4D2

P356

0003-4819-157-4-201208210-00007

P1433

Annals of Internal Medicine

P1476

Benefits and harms of statin t ...... atic review and meta-analysis.

@en

P2093

Fabio Pellegrini

http://www.w3.org/2001/XMLSchema#string

Giovanni F M Strippoli

http://www.w3.org/2001/XMLSchema#string

Marcello Tonelli

http://www.w3.org/2001/XMLSchema#string

Sankar D Navaneethan

http://www.w3.org/2001/XMLSchema#string

Suetonia C Palmer

http://www.w3.org/2001/XMLSchema#string

P2860

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

HMG CoA reductase inhibitors (statins) for dialysis patients

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Meta-analysis in clinical trials

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

P304

263-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-157-4-201208210-00007

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan C. Craig

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22910937

http://www.w3.org/2001/XMLSchema#string

P921

P932

3955032

http://www.w3.org/2001/XMLSchema#string